Immunoblot analysis with antibodies specifically recognizing mesenchymal markers demonstrated elevated CD44 levels in all tested glioma cell cultures, whereas high expression of CHI3L1/YKL40 was found only in WG4 and WG14 cells. The gene discussed is CD44; the disease is central nervous system cancer.